The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 15, 2011
Filed:
Dec. 11, 2009
Joshua Kennedy-smith, San Francisco, CA (US);
Rama K. Kondru, Sunnyvale, CA (US);
Bradley E. Loe, Santa Cruz, CA (US);
Yan Lou, San Jose, CA (US);
Joel Mcintosh, Pacifica, CA (US);
Timothy D. Owens, Mountain View, CA (US);
Michael Soth, Milpitas, CA (US);
Zachary Kevin Sweeney, Redwood City, CA (US);
Joshua Paul Gergely Taygerly, San Francisco, CA (US);
Joshua Kennedy-Smith, San Francisco, CA (US);
Rama K. Kondru, Sunnyvale, CA (US);
Bradley E. Loe, Santa Cruz, CA (US);
Yan Lou, San Jose, CA (US);
Joel McIntosh, Pacifica, CA (US);
Timothy D. Owens, Mountain View, CA (US);
Michael Soth, Milpitas, CA (US);
Zachary Kevin Sweeney, Redwood City, CA (US);
Joshua Paul Gergely Taygerly, San Francisco, CA (US);
Roche Palo Alto LLC, Palo Alto, CA (US);
Abstract
This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-III: wherein, variables R, X, Y, Y, Y, Y, n and m are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formulae I-III and at least one carrier, diluent or excipient.